Researchers in Korea recently identified predictive factors for normalization of thyroid-stimulating immunoglobulin levels in moderate-to-severe Graves’ orbitopathy, highlighting the importance of early treatment.
A smartphone-based machine learning-assisted system for evaluating clinical activity in thyroid-associated orbitopathy may represent a promising new approach to the diagnosis and management of this condition.
This is one of the few studies to have investigated the manifestation and treatment of thyroid eye disease in Black populations. Compared with White patients, Black patients with thyroid eye disease presented with fewer features on clinical exam. Treatments were similar in both groups, however.
Even long after the active phase of thyroid eye disease has subsided, a multitude of challenging quality-of-life issues may persist.
Asymmetric disease may occur in one-third of patients with thyroid eye disease, with muscle volume expansion possibly contributing to the asymmetry. A standardized definition of asymmetry using more objective parameters is needed to facilitate comparisons among studies.
Investigators retrospectively reviewed medical records of patients with thyroid eye disease to determine the most useful biomarker for extraocular muscle enlargement.
.jpg)
.jpg)
